Insulin :: Lilly Introduces World’s First Digital Insulin Pen With Memory
Eli Lilly and Company today announced the launch of the first insulin pen with memory, HumaPen? MEMOIR?, to help simplify the daily management of diabetes.
People
Insulin :: New insulin pen with digital memory simplifies diabetes management
Diabetes management can be overwhelming, and data shows less than half of the 15 million being treated for diabetes have blood sugar levels within the recommended range.
Autism :: Stanford Q&A – Possible genetic links for autism
On Feb. 18, Nature Genetics published the largest-ever study on the genetics of autism. The research is the fruit of an international autism genetics consortium, called the Autism Genome Project.
Herpes :: Herpes treatment could slow HIV progression
The association between genital herpes and higher viral loads of HIV-1 in HIV-infected persons is strong enough to warrant more routine testing for the herpes virus in HIV-positive patients, as well as additional clinical studies of the co-infections, according to an editorial to be published in the New England Journal of Medicine.
HIV :: UN rep expelled after comment on Gambian president’s AIDS cure
The government of The Gambia gave the most senior United Nations official in the country 48 hours to leave the country starting Friday, following remarks she made criticising Gambian President Yahya Jammeh?s widely-publicised cure for HIV/AIDS.
Eye :: 2007 ARVO annual meeting draws spotlight on aging eye
Age-related eye diseases, their treatment, and the latest research to find cures will take center stage at the 2007 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held at the Greater Fort Lauderdale/Broward County Convention Center in Fort Lauderdale, Fla., May 6-10, 2007.
Heart :: Heart Insight for heart patients, families and caregivers
The American Heart Association and Lippincott Williams & Wilkins, part of Wolters Kluwer Health, announce the launch of a new consumer magazine, Heart Insight, for heart patients, their families and caregivers.
Colon Cancer :: 12 myths about colon cancer
Colon cancer is the second leading cause of cancer death in the United States, and the No. 1 cause of cancer death among non-smokers.
Biotechnology :: Acorda Therapeutics Responds to Third Point Letter
Acorda Therapeutics, Inc. (NASDAQ:ACOR) announced that it has received a letter from Third Point LLC dated February 22, 2007.
Multiple Sclerosis :: Pregnancy hormone eases multiple sclerosis
Multiple sclerosis (MS) female patients tends to go into remission while they are pregnant, according to University of Calgary researchers.